News Center
Shanghai Pharma Makes the List of Top 100 Listed Companies in Hong Kong

    Shanghai Pharma made the list of “Top100 Listed Companies in Hong Kong 2015” at the “TOP100 HKAwards” co-sponsored by QQ.COM and FINET, a financial media in Hong Kong.

    Since its successful listing on the Main Board of the Hong Kong Stock Exchange on May 20, 2011, Shanghai Pharma has been enjoying rapid business expansion along with strong vitality. Being viewed as one of the prime pharmaceutical stocks with great development potential, Shanghai Pharma has drawn extensive attention from international institutional investors and stock investors in Hong Kong.

    Shanghai Pharma ranked second in China’s pharmaceutical industry according to the ranking of Top 500 Chinese Companies compiled by China Association of Enterprises in 2015 and topped the list of Top 100 Chinese chemical pharmaceutical companies in terms of comprehensive strength in 2015 according to China Pharmaceutical Industry Association. Shanghai Pharma is one of the few listed pharmaceutical companies taking a leading position in both pharmaceutical manufacturing and distribution markets. It is selected into the sample stocks of both the SSE 180 Index and the CSI 300 Index, with its H-share selected into the constituent stocks of Hang Seng Index and MSCI.

    With its jury committee comprised of senior professionals from major investment banks, security dealers, financial associations as well as accounting and law fields, the “TOP100 HKAwards” is intended to faithfully reflect the endogenous growth momentum and business expansion of enterprises. It has become an important indicator for individual investors and professional investment institutions to select quality stocks, and provides rating reference for the credit business between banks and listed companies. It’s worth mentioning that total return is taken into consideration this time in addition to the fixed dimensions such as total market capitalization, turnover, net profit after tax and return on equity.


The subject of concern
Produced By 大汉网络 大汉版通发布系统